LRP1 and metabolic syndrome: In this view our results emphasize the importance for further investigating the impact of targeting hepatic LRP1 function in the apoE-mediated catabolism of TRL remnants in relation to postprandial dyslipidemia and the other risk factors affecting atherosclerosis development.